MedPath

Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4

Conditions
End Stage Renal Disease
Insulin Resistance
Diabetes
Registration Number
NCT00910130
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Brief Summary

The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Hemodialysis for "End Stage Renal Disease group"
  • Normal Renal Function for "Control group"
Exclusion Criteria
  • Diabetes
  • Malnutrition
  • Malignancy
  • Acute Infection
  • Chronic Active Infection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Giovanni Piotti

🇮🇹

Pavia, Italy

Giovanni Piotti
🇮🇹Pavia, Italy
Giovanni Piotti, MD
Principal Investigator
Teresa Rampino, MD
Contact
+390382503896
t.rampino@smatteo.pv.it
Elisa Gabanti
Sub Investigator
Esposito Pasquale, MD
Sub Investigator
Marilena Gregorini, MD, PHD
Sub Investigator
Giulia Bedino, MD
Sub Investigator
Francesca Bosio, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.